{
    "Case ID": "059291",
    "Crime_Name": [
        "Patent Infringement"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Intellectual Property Dispute"
    ],
    "Legal_Issue": [
        "Whether NOVA Chemicals Corporation infringed Dow's Canadian Patent No. 2,160,705"
    ],
    "Governing_Law": [
        "The Patent Act (Canada)"
    ],
    "Procedural_Stage": [
        "Trial/Adjudication Stage"
    ],
    "Evidence_Assessment": [
        "Expert testimonies, product analysis, strain hardening coefficients, polymer composition data"
    ],
    "Decision_Outcome": [
        "Claims 11, 15, 29, 30, 33, 35, 36, 41, and 42 are valid and infringed by NOVA"
    ],
    "Burden_of_Proof": [
        "On claimant (Dow) to prove infringement by a balance of probabilities"
    ],
    "Credibility_Factor": [
        "Dow's experts provided credible evidence; NOVA failed to rebut sufficiently"
    ],
    "Legal_Rule": [
        "Patent claims must be construed purposively; infringement occurs if all essential elements are present in the accused product"
    ],
    "Standard_of_Review": [
        "Purposive construction of patent claims"
    ],
    "Procedural_Issue": [
        "Claim construction, validity challenges (novelty, obviousness, sufficiency, double patenting)"
    ],
    "Grounds_for_Claim": [
        "Manufacturing and selling polyethylene compositions that embody the patented invention"
    ],
    "Outcome_on_Merits": [
        "In favor of Dow; infringement established"
    ],
    "Decision_Maker": [
        "Court (Federal Court of Canada)"
    ],
    "Judicial_Review_Outcome": [
        "Not applicable â€“ this was a trial-level decision"
    ],
    "Review_Standard": [
        "Balance of probabilities"
    ],
    "Procedural_Fairness_Assessment": [
        "Fair hearing conducted with opportunity for both parties to present evidence and argument"
    ],
    "Key_Evidence_Considered": [
        "SURPASS polymer composition, strain hardening data, expert reports, patent claims"
    ],
    "Legal_Framework": [
        "Canadian patent law under the Patent Act"
    ],
    "Applicant_Challenge": [
        "Dow challenged NOVA's use of patented technology without authorization"
    ],
    "Court_Result": [
        "Dow succeeded on validity and infringement"
    ],
    "Legal_Rule_Source": [
        "Patent Act, Canadian case law on purposive claim construction"
    ],
    "Standard_of_Proof": [
        "Balance of probabilities"
    ],
    "Defendant_Response": [
        "NOVA denied infringement and challenged validity but failed to provide sufficient counter-evidence"
    ],
    "Evidence_Type": [
        "Scientific/technical evidence, documentary evidence, expert testimony"
    ],
    "Remedy_Requested": [
        "Accounting of profits, damages, reasonable compensation, pre- and post-judgment interest"
    ],
    "Outcome": [
        "Remedies granted as per Patent Act; NOVA liable for infringement"
    ],
    "Decision_Authority": [
        "Federal Court of Canada"
    ],
    "Remedy_Sought": [
        "Monetary relief and declaration of infringement"
    ],
    "Resolution_Mechanism": [
        "Judicial determination after trial"
    ],
    "Legal_Provision": [
        "Patent Act, R.S.C. 1985, c. P-4"
    ],
    "Authority": [
        "Federal Court of Canada"
    ],
    "Claimant_Status": [
        "Patent holder (Dow Chemical Company)"
    ],
    "Legal_Provision_Cited": [
        "Canadian Patent No. 2,160,705"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Infringement based on inclusion of essential elements of patented claims"
    ],
    "Applicable_Process": [
        "Civil litigation process under Canadian federal law"
    ],
    "Outcome_of_Review": [
        "No appeal mentioned; decision stands at trial level"
    ],
    "Pending_Relief_or_Application": [
        "Award of remedies pending calculation or agreement"
    ],
    "Jurisdiction": [
        "Federal jurisdiction (intellectual property)"
    ],
    "Governing_Rule": [
        "Purposive construction of patent claims; requirements for utility, novelty, non-obviousness"
    ]
}